205 related articles for article (PubMed ID: 26106330)
21. Drug interactions between buprenorphine, methadone and hepatitis C therapeutics.
Ogbuagu O; Friedland G; Bruce RD
Expert Opin Drug Metab Toxicol; 2016 Jul; 12(7):721-31. PubMed ID: 27140427
[TBL] [Abstract][Full Text] [Related]
22. Switching Opioid-Dependent Patients From Methadone to Morphine: Safety, Tolerability, and Methadone Pharmacokinetics.
Glue P; Cape G; Tunnicliff D; Lockhart M; Lam F; Gray A; Hung N; Hung CT; Harland S; Devane J; Howes J; Weis H; Friedhoff L
J Clin Pharmacol; 2016 Aug; 56(8):960-5. PubMed ID: 26763764
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics and pharmacodynamics of methadone enantiomers after coadministration with amprenavir in opioid-dependent subjects.
Hendrix CW; Wakeford J; Wire MB; Lou Y; Bigelow GE; Martinez E; Christopher J; Fuchs EJ; Snidow JW
Pharmacotherapy; 2004 Sep; 24(9):1110-21. PubMed ID: 15460171
[TBL] [Abstract][Full Text] [Related]
24. Non-prescribed use of methadone and buprenorphine prior to opioid substitution treatment: lifetime prevalence, motives, and drug sources among people with opioid dependence in five Swedish cities.
Johnson B; Richert T
Harm Reduct J; 2019 May; 16(1):31. PubMed ID: 31046774
[TBL] [Abstract][Full Text] [Related]
25. Actual and potential drug interactions associated with methadone.
Weschules DJ; Bain KT; Richeimer S
Pain Med; 2008 Apr; 9(3):315-44. PubMed ID: 18386306
[TBL] [Abstract][Full Text] [Related]
26. Genders and the concurrent use of cocaine and alcohol: Pharmacological aspects.
Graziani M; Nencini P; Nisticò R
Pharmacol Res; 2014 Sep; 87():60-70. PubMed ID: 24972039
[TBL] [Abstract][Full Text] [Related]
27. Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation?
Mayet S; Gossop M; Lintzeris N; Markides V; Strang J
Drug Alcohol Rev; 2011 Jul; 30(4):388-96. PubMed ID: 21355918
[TBL] [Abstract][Full Text] [Related]
28. Methadone overdose and cardiac arrhythmia potential: findings from a review of the evidence for an American Pain Society and College on Problems of Drug Dependence clinical practice guideline.
Chou R; Weimer MB; Dana T
J Pain; 2014 Apr; 15(4):338-65. PubMed ID: 24685459
[TBL] [Abstract][Full Text] [Related]
29. [Methadone--pharmacokinetics and pharmacodynamics of an opiate].
Jage J
Anaesthesist; 1989 Apr; 38(4):159-66. PubMed ID: 2567128
[TBL] [Abstract][Full Text] [Related]
30. Constipation and other common symptoms reported by women and men in methadone and buprenorphine maintenance treatment.
Haber PS; Elsayed M; Espinoza D; Lintzeris N; Veillard AS; Hallinan R
Drug Alcohol Depend; 2017 Dec; 181():132-139. PubMed ID: 29054032
[TBL] [Abstract][Full Text] [Related]
31. Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation.
Connock M; Juarez-Garcia A; Jowett S; Frew E; Liu Z; Taylor RJ; Fry-Smith A; Day E; Lintzeris N; Roberts T; Burls A; Taylor RS
Health Technol Assess; 2007 Mar; 11(9):1-171, iii-iv. PubMed ID: 17313907
[TBL] [Abstract][Full Text] [Related]
32. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence.
Mattick RP; Breen C; Kimber J; Davoli M
Cochrane Database Syst Rev; 2003; (2):CD002209. PubMed ID: 12804430
[TBL] [Abstract][Full Text] [Related]
33. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence.
Mattick RP; Breen C; Kimber J; Davoli M
Cochrane Database Syst Rev; 2002; (4):CD002209. PubMed ID: 12519570
[TBL] [Abstract][Full Text] [Related]
34. Steady-state pharmacokinetics and pharmacodynamics in methadone maintenance patients: comparison of those who do and do not experience withdrawal and concentration-effect relationships.
Dyer KR; Foster DJ; White JM; Somogyi AA; Menelaou A; Bochner F
Clin Pharmacol Ther; 1999 Jun; 65(6):685-94. PubMed ID: 10391674
[TBL] [Abstract][Full Text] [Related]
35. [Review of cases of prolonged QTC and wave burst arrhythmia in patients treated with methadone].
Laqueille X; Richa S; Kerbage H; Scart-Gres C; Berleur MP
Encephale; 2012 Feb; 38(1):58-63. PubMed ID: 22381725
[TBL] [Abstract][Full Text] [Related]
36. Chronic and acute pain and pain management for patients in methadone maintenance treatment.
Eyler EC
Am J Addict; 2013 Jan; 22(1):75-83. PubMed ID: 23398230
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics and pharmacodynamics of the injectable formulation of methadone hydrochloride and methadone in lipid nanocarriers administered orally to horses.
Crosignani N; Luna SP; Dalla Costa T; Pimenta EL; Detoni CB; Guterres SS; Puoli Filho JN; Pantoja JC; Pigatto MC
J Vet Pharmacol Ther; 2017 Aug; 40(4):398-405. PubMed ID: 28092108
[TBL] [Abstract][Full Text] [Related]
38. Gender differences in access to methadone maintenance therapy in a Canadian setting.
Bach P; Milloy MJ; Nguyen P; Koehn J; Guillemi S; Kerr T; Wood E
Drug Alcohol Rev; 2015 Sep; 34(5):503-507. PubMed ID: 25735544
[TBL] [Abstract][Full Text] [Related]
39. Methadone related deaths compared to all prescription related deaths.
Lev R; Petro S; Lee A; Lee O; Lucas J; Castillo EM; Egnatios J; Vilke GM
Forensic Sci Int; 2015 Dec; 257():347-352. PubMed ID: 26513639
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
